Biogen Dividends and Buybacks
Dividend criteria checks 0/6
Biogen does not have a record of paying a dividend.
Key information
n/a
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 0% |
| Future Dividend Yield | 0% |
| Dividend Growth | n/a |
| Next dividend pay date | n/a |
| Ex dividend date | n/a |
| Dividend per share | n/a |
| Payout ratio | n/a |
Recent dividend and buyback updates
No updates
Recent updates
Biogen Q3 Earnings Review: Why I Remain Optimistic Despite Difficult Quarter
Oct 31Does Biogen (NASDAQ:BIIB) Have A Healthy Balance Sheet?
Oct 01
What You Can Learn From Biogen Inc.'s (NASDAQ:BIIB) P/E
Sep 04Biogen: Q2 Earnings, Share Price May Have Bottomed Out As CEO Makes Mark
Aug 17Biogen Stock: Cheapish, But With Few Growth Prospects
Jul 11Is Biogen (NASDAQ:BIIB) Using Too Much Debt?
May 23Biogen's Revenue Dip Meets Cost Cuts In Q1 (Rating Upgrade)
Apr 29Earnings Update: Biogen Inc. (NASDAQ:BIIB) Just Reported Its First-Quarter Results And Analysts Are Updating Their Forecasts
Apr 28The Price Is Right For Biogen Inc. (NASDAQ:BIIB)
Apr 15We Think You Can Look Beyond Biogen's (NASDAQ:BIIB) Lackluster Earnings
Feb 21Biogen Inc. Just Missed EPS By 21%: Here's What Analysts Think Will Happen Next
Feb 16Biogen's Q4 Earnings Disappoint Amidst Strategic Challenges (Rating Downgrade)
Feb 14Here's Why Biogen (NASDAQ:BIIB) Can Manage Its Debt Responsibly
Jan 31Biotech And Pharma Diversification Pays Off
Jan 25Getting In Cheap On Biogen Inc. (NASDAQ:BIIB) Might Be Difficult
Dec 26An Intrinsic Calculation For Biogen Inc. (NASDAQ:BIIB) Suggests It's 49% Undervalued
Oct 21Is Biogen (NASDAQ:BIIB) Using Too Much Debt?
Oct 03Is Biogen Inc. (NASDAQ:BIIB) Trading At A 31% Discount?
Jul 16Stability and Growth of Payments
Fetching dividends data
Stable Dividend: Insufficient data to determine if BIIB's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if BIIB's dividend payments have been increasing.
Dividend Yield vs Market
| Biogen Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (BIIB) | n/a |
| Market Bottom 25% (US) | 1.4% |
| Market Top 25% (US) | 4.2% |
| Industry Average (Biotechs) | 2.3% |
| Analyst forecast (BIIB) (up to 3 years) | 0% |
Notable Dividend: Unable to evaluate BIIB's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate BIIB's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Earnings Payout to Shareholders
Earnings Coverage: Insufficient data to calculate BIIB's payout ratio to determine if its dividend payments are covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: Unable to calculate sustainability of dividends as BIIB has not reported any payouts.